Squadron Capital Management LLC — 13F Holdings

2026 Q3  ·  64 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Squadron Capital Management LLC maintained a portfolio of 64 distinct positions. The most significant new addition was SILENCE THERAPEUTICS PLC, now representing 5.72% of the total fund value. They heavily accumulated shares in C4 THERAPEUTICS INC, increasing the position by 2229.7%. The fund also reduced its exposure to RELMADA THERAPEUTICS INC by 52.4%.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
64
Quarter
2026 Q3
Top Holding
KOD (10.0%)
Top 10 Concentration
56.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 64

Squadron Capital Management LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
KOD
KODIAK SCIENCES...
Healthcare 9.99% 6.05% #1 3
Prev: #4
6.5
—
-80,000 -16.0%
P
S
420,000 $39,816,000
$46.80 +109.2%
$94.80 +3.3%
2025 Q4 13F Filing 2026-09-30 2026-11-16
CCCC
C4 THERAPEUTICS...
Healthcare 7.79% 10.43% #2
Prev: #2
7.1
—
2,118,683 29.4%
P
S
9,318,683 $31,031,214 2026 Q1 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 7.35% 10.39% #3
Prev: #3
5.9
—
50,000 5.8%
P
S
915,000 $29,298,300 2025 Q4 13F Filing 2026-09-30 2026-11-16
KOD
KODIAK SCIENCES...
CALL
CALL Option 6.42% — #4
Prev: #—
6.6
—
270,000 —
NEW
270,000 $25,596,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
SLN
SILENCE THERAPE...
Healthcare 5.72% — #5
Prev: #—
6.3
—
2,085,000 —
NEW
2,085,000 $22,789,050 2026 Q3 13F Filing 2026-09-30 2026-11-16
ZNTL
ZENTALIS PHARMA...
Healthcare 4.75% 5.57% #6
Prev: #6
4.9
—
3,127,905 84.5%
P
S
6,827,905 $18,913,297 2026 Q1 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 4.33% 3.66% #7
Prev: #7
4.2
—
135,000 46.6%
P
S
425,000 $17,255,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 3.56% 5.63% #8 3
Prev: #5
1.9
—
-185,000 -19.1%
P
S
785,000 $14,169,250 2026 Q1 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 3.38% — #9
Prev: #—
4.9
—
1,000,000 —
NEW
1,000,000 $13,470,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
RLMD
RELMADA THERAPE...
Healthcare 3.31% 15.78% #10 9
Prev: #1
1.3
—
-3,850,000 -52.4%
P
S
3,500,000 $13,195,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
DFTX
DEFINIUM THERAP...
Healthcare 3.25% 1.24% #11 14
Prev: #25
4.3
—
255,000 300.0%
P
S
340,000 $12,940,400 2026 Q2 13F Filing 2026-09-30 2026-11-16
PHVS
PHARVARIS N V
Healthcare 3.18% — #12
Prev: #—
4.8
—
400,000 —
NEW
400,000 $12,688,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
ANL
ADLAI NORTYE GR...
Healthcare 3.07% 2.73% #13 3
Prev: #10
2.2
—
no change no change
P
S
764,876 $12,238,016 2026 Q1 13F Filing 2026-09-30 2026-11-16
VERA
VERA THERAPEUTI...
Healthcare 2.47% — #14
Prev: #—
4.5
—
305,000 —
NEW
305,000 $9,848,450 2025 Q4 13F Filing 2026-09-30 2026-11-16
IVA
INVENTIVA SA
Healthcare 2.22% 2.86% #15 6
Prev: #9
1.4
—
-35,000 -1.4%
P
S
2,400,000 $8,856,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
IRON
DISC MEDICINE I...
CALL
CALL Option 2.21% 0.68% #16 14
Prev: #30
3.9
—
104,500 348.3%
P
S
134,500 $8,804,370 2026 Q2 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
CALL
CALL Option 2.13% — #17
Prev: #—
4.4
—
265,000 —
NEW
265,000 $8,485,300 2025 Q4 13F Filing 2026-09-30 2026-11-16
AVTX
AVALO THERAPEUT...
Healthcare 1.73% — #18
Prev: #—
4.2
—
450,000 —
NEW
450,000 $6,898,500 2025 Q4 13F Filing 2026-09-30 2026-11-16
ACRS
ACLARIS THERAPE...
Healthcare 1.58% — #19
Prev: #—
4.1
—
1,200,000 —
NEW
1,200,000 $6,312,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
RZLT
REZOLUTE INC
CALL
CALL Option 1.38% 1.45% #20 2
Prev: #18
3.1
—
423,500 47.1%
P
S
1,323,500 $5,479,290 2026 Q2 13F Filing 2026-09-30 2026-11-16
ASMB
ASSEMBLY BIOSCI...
Healthcare 1.33% 1.36% #21 1
Prev: #20
3.0
—
65,000 40.6%
P
S
225,000 $5,285,250 2026 Q2 13F Filing 2026-09-30 2026-11-16
ADAG
ADAGENE INC
Healthcare 1.30% 1.63% #22 6
Prev: #16
3.0
—
366,618 29.3%
P
S
1,616,618 $5,173,178 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
CRESCENT BIOPHA...
Unknown 1.28% — #23
Prev: #—
4.0
—
350,000 —
NEW
350,000 $5,106,500 — 13F Filing 2026-09-30 2026-11-16
YARW
YARROW BIOSCIEN...
Healthcare 1.27% — #24
Prev: #—
4.0
—
225,000 —
NEW
225,000 $5,067,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
ZURA
ZURA BIO LTD
Healthcare 1.25% — #25
Prev: #—
4.0
—
1,200,000 —
NEW
1,200,000 $4,992,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
N/A
TCGX ACQUISITIO...
Unknown 1.16% — #26
Prev: #—
4.0
—
370,220 —
NEW
370,220 $4,631,452 — 13F Filing 2026-09-30 2026-11-16
CTNM
CONTINEUM THERA...
Healthcare 1.09% 1.32% #27 4
Prev: #23
2.9
—
63,570 24.4%
P
S
323,570 $4,342,309 2026 Q2 13F Filing 2026-09-30 2026-11-16
AVBP
ARRIVENT BIOPHA...
CALL
CALL Option 1.08% 1.97% #28 16
Prev: #12
0.4
—
-40,500 -22.1%
P
S
142,500 $4,314,900 2025 Q4 13F Filing 2026-09-30 2026-11-16
IKT
INHIBIKASE THER...
Healthcare 1.03% 1.89% #29 14
Prev: #15
0.4
—
-1,000,000 -33.3%
P
S
2,000,000 $4,110,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
PALI
PALISADE BIO IN...
Healthcare 1.02% 1.95% #30 17
Prev: #13
1.4
—
no change no change
P
S
3,000,000 $4,050,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 0.94% — #31
Prev: #—
3.9
—
150,000 —
NEW
150,000 $3,742,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
JANX
JANUX THERAPEUT...
Healthcare 0.93% — #32
Prev: #—
3.9
—
215,000 —
NEW
215,000 $3,715,200 2026 Q3 13F Filing 2026-09-30 2026-11-16
SVRA
SAVARA INC
Healthcare 0.87% — #33
Prev: #—
3.8
—
675,000 —
NEW
675,000 $3,483,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
CTNM
CONTINEUM THERA...
CALL
CALL Option 0.76% — #34
Prev: #—
3.8
—
225,000 —
NEW
225,000 $3,019,500 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
QUINCE THERAPEU...
Unknown 0.70% 0.23% #35 3
Prev: #38
3.3
—
49,625 122.9%
P
S
90,000 $2,790,900 — 13F Filing 2026-09-30 2026-11-16
N/A
JATT III ACQUIS...
Unknown 0.69% — #36
Prev: #—
3.8
—
250,000 —
NEW
250,000 $2,755,000 — 13F Filing 2026-09-30 2026-11-16
SCYX
SCYNEXIS INC
Healthcare 0.64% 0.96% #37 9
Prev: #28
0.3
—
-241,839 -32.0%
P
S
515,045 $2,544,322 2026 Q1 13F Filing 2026-09-30 2026-11-16
SLN
SILENCE THERAPE...
CALL
CALL Option 0.49% — #38
Prev: #—
3.7
—
180,000 —
NEW
180,000 $1,967,400 2026 Q3 13F Filing 2026-09-30 2026-11-16
ALXO
ALX ONCOLOGY HL...
Healthcare 0.49% — #39
Prev: #—
3.7
—
1,400,000 —
NEW
1,400,000 $1,946,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
LPCN
LIPOCINE INC NE...
Healthcare 0.45% 0.64% #40 8
Prev: #32
1.2
—
no change no change
P
S
810,000 $1,782,000 2025 Q4 13F Filing 2026-09-30 2026-11-16
BIOA
BIOAGE LABS INC
CALL
CALL Option 0.44% 1.90% #41 27
Prev: #14
1.2
—
no change no change
P
S
250,000 $1,772,500 2026 Q2 13F Filing 2026-09-30 2026-11-16
PEPG
PEPGEN INC
Healthcare 0.36% — #42
Prev: #—
3.6
—
600,000 —
NEW
600,000 $1,452,000 2026 Q3 13F Filing 2026-09-30 2026-11-16
CCCC
C4 THERAPEUTICS...
CALL
CALL Option 0.33% 0.58% #43 9
Prev: #34
1.1
—
no change no change
P
S
400,000 $1,332,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
N/A
JATT II ACQUISI...
Unknown 0.18% — #44
Prev: #—
3.6
—
65,000 —
NEW
65,000 $730,925 — 13F Filing 2026-09-30 2026-11-16
ZNTL
ZENTALIS PHARMA...
CALL
CALL Option 0.07% 0.64% #45 12
Prev: #33
0.0
—
-326,000 -76.5%
P
S
100,000 $277,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
NXTC
NEXTCURE INC
Healthcare 0.00% 0.03%
Sold All 😨
(Was: #43)
0.0
—
-64,464 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
NMRA
NEUMORA THERAPE...
Healthcare 0.00% 0.05%
Sold All 😨
(Was: #42)
0.0
—
-100,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
INM
INMED PHARMACEU...
Healthcare 0.00% 0.16%
Sold All 😨
(Was: #41)
0.0
—
-325,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
KTTA
PASITHEA THERAP...
Healthcare 0.00% 0.16%
Sold All 😨
(Was: #40)
0.0
—
-1,000,000 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
NVCT
NUVECTIS PHARMA...
CALL
CALL Option 0.00% 0.22%
Sold All 😨
(Was: #39)
0.0
—
-38,700 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 64 holdings

Unlock Full Squadron Capital Management LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →